IL268013D0 - Tetrahydropyrazolopyrimidine compounds - Google Patents

Tetrahydropyrazolopyrimidine compounds

Info

Publication number
IL268013D0
IL268013D0 IL268013A IL26801319A IL268013D0 IL 268013 D0 IL268013 D0 IL 268013D0 IL 268013 A IL268013 A IL 268013A IL 26801319 A IL26801319 A IL 26801319A IL 268013 D0 IL268013 D0 IL 268013D0
Authority
IL
Israel
Prior art keywords
tetrahydropyrazolopyrimidine
compounds
tetrahydropyrazolopyrimidine compounds
Prior art date
Application number
IL268013A
Other languages
Hebrew (he)
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261654023P priority Critical
Priority to PCT/US2013/043679 priority patent/WO2013181579A2/en
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of IL268013D0 publication Critical patent/IL268013D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials
IL268013A 2012-05-31 2019-07-11 Tetrahydropyrazolopyrimidine compounds IL268013D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201261654023P true 2012-05-31 2012-05-31
PCT/US2013/043679 WO2013181579A2 (en) 2012-05-31 2013-05-31 Tetrahydropyrazolopyrimidine compounds

Publications (1)

Publication Number Publication Date
IL268013D0 true IL268013D0 (en) 2019-09-26

Family

ID=48626649

Family Applications (2)

Application Number Title Priority Date Filing Date
IL23598614A IL235986A (en) 2012-05-31 2014-11-30 Tetrahydropyrazolopyrimidine compounds
IL268013A IL268013D0 (en) 2012-05-31 2019-07-11 Tetrahydropyrazolopyrimidine compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL23598614A IL235986A (en) 2012-05-31 2014-11-30 Tetrahydropyrazolopyrimidine compounds

Country Status (31)

Country Link
US (5) US9126999B2 (en)
EP (1) EP2855476B1 (en)
JP (2) JP6285918B2 (en)
KR (1) KR20150016366A (en)
CN (2) CN104507939B (en)
AR (1) AR091236A1 (en)
AU (2) AU2013267204B8 (en)
BR (1) BR112014030060A2 (en)
CA (1) CA2874445A1 (en)
CL (1) CL2014003278A1 (en)
DK (1) DK2855476T3 (en)
ES (1) ES2709119T3 (en)
HK (1) HK1203498A1 (en)
HR (1) HRP20181889T1 (en)
HU (1) HUE040562T2 (en)
IL (2) IL235986A (en)
LT (1) LT2855476T (en)
MX (1) MX368455B (en)
NZ (1) NZ703459A (en)
PE (2) PE20190973A1 (en)
PH (1) PH12014502660B1 (en)
PL (1) PL2855476T3 (en)
PT (1) PT2855476T (en)
RS (1) RS57977B1 (en)
RU (2) RU2733959C2 (en)
SG (1) SG11201407890VA (en)
SI (1) SI2855476T1 (en)
TW (1) TWI572606B (en)
UA (1) UA113440C2 (en)
WO (1) WO2013181579A2 (en)
ZA (1) ZA201409273B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2855476T1 (en) * 2012-05-31 2018-12-31 Eisai R&D Management Co., Ltd. Tetrahydropyrazolopyrimidine compounds
TWI652014B (en) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 The bicyclic heterocycle substituted azole pesticides
AU2014334554B2 (en) 2013-10-14 2018-12-06 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
US9663486B2 (en) 2013-10-14 2017-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CN105992766A (en) * 2013-12-13 2016-10-05 武田药品工业株式会社 Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
WO2015144801A1 (en) * 2014-03-27 2015-10-01 Janssen Pharmaceutica Nv SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND 2,3-DIHYDRO-1H-IMIDAZO[1,2-b]PYRAZOLE DERIVATIVES AS ROS1 INHIBITORS
RU2712192C2 (en) 2014-07-31 2020-01-24 Басф Се Method of producing pyrazoles
US9938100B2 (en) 2014-12-30 2018-04-10 Kodak Alaris Inc. System and method for metallic object detection in a media transport system
CA2984703A1 (en) 2015-05-11 2016-11-17 Basf Se Process for preparing 4-amino-pyridazines
WO2017004734A1 (en) * 2015-07-03 2017-01-12 中国农业大学 Benzyl hydrazone compound, and preparation method and use thereof
PL3411360T3 (en) * 2016-02-02 2020-08-24 Basf Se Catalytic hydrogenation process for preparing pyrazoles
CN107174585A (en) * 2016-03-10 2017-09-19 兰州大学 It can be used as the new application of the pyridine-imidazole class compound of androgen receptor antagonists
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CN109923108A (en) 2016-09-09 2019-06-21 百时美施贵宝公司 The benzazolyl compounds that pyridyl group replaces
EP3636646A4 (en) * 2017-05-18 2020-12-09 Jiangsu Hengrui Medicine Co Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereof
KR102037494B1 (en) 2017-12-11 2019-10-28 씨제이헬스케어 주식회사 Intermediates of chiral piperidine derivatives and preparation method thereof
BR112020011668A2 (en) * 2017-12-15 2020-11-17 Bristol-Myers Squibb Company substituted indole ether compounds
WO2019125977A1 (en) * 2017-12-18 2019-06-27 Bristol-Myers Squibb Company 4-azaindole compounds
EP3728225A1 (en) * 2017-12-19 2020-10-28 Bristol-Myers Squibb Company Substituted indole compounds useful as tlr inhibitors
BR112020011979A2 (en) * 2017-12-19 2020-11-17 Bristol-Myers Squibb Company amide-substituted indole compounds useful as tlr inhibitors
WO2019123294A2 (en) 2017-12-22 2019-06-27 Novartis Ag Novel uses of pyrazolo piperidine derivatives
WO2019122164A1 (en) * 2017-12-22 2019-06-27 Solvay Sa Process for the manufacture of pyrazole carboxylic derivatives and precursors thereof
WO2019235553A1 (en) * 2018-06-07 2019-12-12 第一三共株式会社 Azetidine derivative, and prodrug thereof
WO2020048596A1 (en) * 2018-09-06 2020-03-12 F. Hoffmann-La Roche Ag Novel pyrazolopyridine compounds for the treatment of autoimmune disease
WO2020160711A1 (en) * 2019-02-07 2020-08-13 Beigene, Ltd. Imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivatives as tlr7 agonist
KR20190120112A (en) 2019-10-08 2019-10-23 씨제이헬스케어 주식회사 Intermediates of chiral piperidine derivatives and preparation method thereof

Family Cites Families (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3116230B2 (en) 1989-02-15 2000-12-11 武田薬品工業株式会社 Tricyclic fused pyrimidine derivatives
JPH04133055A (en) 1990-09-25 1992-05-07 Konica Corp Silver halide color photographic sensitive material improved in color reproducibility
US5356897A (en) 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
FR2733749B1 (en) 1995-05-05 1997-06-13 Oreal Compositions for dyeing keratinic fibers containing diamino pyrazoles, dyeing process, novel diamino pyrazoles, and preparation method thereof
DE19709877A1 (en) 1997-03-11 1998-09-17 Bayer Ag 1,5-dihydro-pyrazolo [3,4-d] pyrimidinone derivatives
US6472416B1 (en) 1999-08-27 2002-10-29 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
US6635638B2 (en) 2000-05-17 2003-10-21 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
KR20040015036A (en) 2000-12-06 2004-02-18 아벤티스 파마 도이칠란트 게엠베하 Guanidine and amidine derivatives as factor Xa inhibitors
AT404568T (en) * 2001-03-14 2008-08-15 Gruenenthal Gmbh Substituted thiazolopyrimidines as analgetics
ES2247527T3 (en) 2002-04-26 2006-03-01 Pfizer Prod Inc Metaloproteinase triaril-oxi-aril-espiro-pyrimidine-2,4,6-triona inhibitors.
DE10221100C1 (en) 2002-05-03 2003-06-05 Neuhaus Elektronik Gmbh Electrically conducting seal, consists of an elastically hardenable material that contains magnetic particles, which is extruded onto a surface and then subjected to a magnetic field
JP2003327860A (en) 2002-05-09 2003-11-19 Konica Minolta Holdings Inc Colored composition, colored microparticle dispersion, ink for ink jet and method for ink jet recording
CA2490239C (en) 2002-06-19 2011-05-24 Janssen Pharmaceutica N.V. Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
JP4133055B2 (en) 2002-07-11 2008-08-13 株式会社イトーキ Automated warehouse with transfer mechanism
CN1771231B (en) * 2002-08-26 2011-05-25 武田药品工业株式会社 Calcium receptor modulating compound and use thereof
EP1572113B1 (en) 2002-08-26 2017-05-17 Takeda Pharmaceutical Company Limited Calcium receptor modulating compound and use thereof
WO2004037159A2 (en) 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
SE0300120D0 (en) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
WO2004089415A2 (en) * 2003-04-11 2004-10-21 Novo Nordisk A/S COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
EP1618094B1 (en) 2003-04-30 2007-09-05 The Institutes for Pharmaceutical Discovery, LLC Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
US7329680B2 (en) 2003-04-30 2008-02-12 The Institute For Pharmaceutical Discovery, Llc Heterocycle substituted carboxylic acids
CN1805928A (en) 2003-06-12 2006-07-19 麦克公司 Prodrugs of mitotic kinesin inhibitors
US20060084135A1 (en) 2003-07-01 2006-04-20 Howitz Konrad T Compositions for manipulating the lifespan and stress response of cells and organisms
US20060025337A1 (en) 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
GB0324159D0 (en) 2003-10-15 2003-11-19 Glaxo Group Ltd Novel compounds
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
FR2865208B1 (en) 2004-01-16 2009-01-16 Sanofi Synthelabo 1,4-diazabicyclo [3.2.1] octanecarboxmique derivatives, their preparation and therapeutic use thereof
US7279232B2 (en) 2004-01-26 2007-10-09 Universal Display Corporation Electroluminescent stability
US20080004263A1 (en) 2004-03-04 2008-01-03 Santora Vincent J Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
CN1997618A (en) 2004-05-04 2007-07-11 阿卡迪亚医药公司 Compounds with activity at estrogen receptors
US7825265B2 (en) 2004-05-04 2010-11-02 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptors
KR20070085340A (en) 2004-10-12 2007-08-27 디코드 제네틱스, 아이엔씨. Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
EP1844043A2 (en) 2004-11-18 2007-10-17 The Institutes for Pharmaceutical Discovery, LLC Heterocycle substituted carboxylic acids for the treatment of diabetes
JPWO2006057448A1 (en) 2004-11-26 2008-06-05 武田薬品工業株式会社 Arylalkanoic acid derivatives
CA2595486A1 (en) 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
CA2610854A1 (en) 2005-03-30 2006-10-05 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
WO2006129587A1 (en) 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. Pharmaceutical composition comprising pyrazolone derivative
WO2006129583A1 (en) 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. Pyrazolone derivative
WO2006133216A2 (en) 2005-06-06 2006-12-14 Smithkline Beecham Corporation 4-substituted arylamine derivatives and their use in pharmaceutical compositions
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
GB0513886D0 (en) 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
US20070149466A1 (en) 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
WO2007008541A2 (en) 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers
AU2006285599A1 (en) 2005-09-01 2007-03-08 Astellas Pharma Inc. Pyridazinone derivatives used for the treatment of pain
US20070203236A1 (en) 2006-01-11 2007-08-30 Smith Jeffrey W Novel antagonists of the human fatty acid synthase thioesterase
US7915305B2 (en) 2006-01-23 2011-03-29 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007102531A1 (en) 2006-03-08 2007-09-13 Takeda Pharmaceutical Company Limited Pharmaceutical combination
WO2007125320A1 (en) 2006-04-25 2007-11-08 Astex Therapeutics Limited Pharmaceutical compounds
CN101495474A (en) 2006-05-23 2009-07-29 沃泰克斯药物股份有限公司 Thiophene-carboxamides useful as inhibitors of protein kinases
CA2652816A1 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
MX2008015638A (en) 2006-06-09 2009-01-09 Icos Corp Substituted phenyl acetic acids as dp-2 antagonists.
CA2657227A1 (en) 2006-07-14 2008-01-17 Novartis Ag Pyrimidine derivatives as alk-5 inhibitors
MX2009001036A (en) 2006-08-04 2009-04-23 Merz Pharma Gmbh & Co Kgaa Pyrazolopyrimidines, a process for their preparation and their use as medicine.
WO2008033894A2 (en) 2006-09-14 2008-03-20 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptors
CN101534824A (en) 2006-11-17 2009-09-16 艾博特公司 Aminopyrrolidines as chemokine receptor antagonists
PE20081581A1 (en) 2006-12-21 2008-11-12 Plexxikon Inc COMPOUNDS pyrrolo [2,3-b] pyridines KINASE MODULATORS AS
GB0625659D0 (en) 2006-12-21 2007-01-31 Cancer Rec Tech Ltd Therapeutic compounds and their use
MX2009008253A (en) 2007-01-31 2009-10-12 Vertex Pharma Kinase inhibitors.
CA2677296A1 (en) 2007-02-08 2008-08-14 Merck & Co., Inc. Therapeutic agents
EP2009002A1 (en) 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
EP2170337A4 (en) 2007-06-28 2013-12-18 Abbvie Inc Novel triazolopyridazines
US8022209B2 (en) 2007-09-12 2011-09-20 Janssen Pharmaceutica Nv Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
EP2220087A1 (en) * 2007-11-15 2010-08-25 Eisai R&D Management Co., Ltd. Enantiomerically enriched imidazoazepinone compounds
EP2280766A1 (en) * 2007-12-11 2011-02-09 CytoPathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
AR070127A1 (en) 2008-01-11 2010-03-17 Novartis Ag Pyrrolo - pyrrolo pyrimidines and pyridines
PT2231642E (en) 2008-01-11 2014-03-12 Novartis Ag Pyrimidines as kinase inhibitors
US20120010177A1 (en) 2008-02-20 2012-01-12 The Wistar Institute / North Carolina State University MicroRNA Modulators and Method for Identifying And Using The Same
US8338392B2 (en) 2008-02-20 2012-12-25 The Wistar Institute MicroRNA modulators and method for identifying and using the same
WO2009111207A1 (en) 2008-03-04 2009-09-11 Merck & Co., Inc. Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
US9066951B2 (en) 2008-05-29 2015-06-30 Wisconsin Alumni Research Foundation Drugs to treat HPV infection
AU2009257795A1 (en) 2008-06-11 2009-12-17 Merck Sharp & Dohme Corp. Pyrazole derivatives useful as inhibitors of FAAH
EP2300438A4 (en) 2008-06-11 2012-06-27 Merck Sharp & Dohme Imidazole derivatives useful as inhibitors of faah
CA2724998A1 (en) 2008-06-18 2009-12-23 Pfizer Limited Nicotinamide derivatives
US20110306597A1 (en) 2008-06-18 2011-12-15 James Michael Crawforth Nicotinamide Derivatives
CN102076686B (en) 2008-06-25 2013-03-06 百时美施贵宝公司 Diketopiperidine derivatives as HIV attachment inhibitors
WO2009158394A1 (en) 2008-06-25 2009-12-30 Bristol-Myers Squibb Company Diketo azolopiperidines and azolopiperazines as anti-hiv agents
US8263642B2 (en) 2008-06-25 2012-09-11 Vanderbilt University Antimicrobial compounds and methods of use thereof
TWI461423B (en) 2008-07-02 2014-11-21 Astrazeneca Ab Thiazolidinedione compounds useful in the treatment of pim kinase related conditions and diseases
EP2326622A1 (en) 2008-07-28 2011-06-01 Gilead Sciences, Inc. Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
WO2010017079A1 (en) 2008-08-04 2010-02-11 Merck & Co., Inc. Oxazole derivatives useful as inhibitors of faah
WO2010019392A1 (en) 2008-08-13 2010-02-18 Merck Sharp & Dohme Corp. Purine derivatives for treatment of alzheimer's disease
JP5555236B2 (en) 2008-08-25 2014-07-23 アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc Hedgehog pathway modulator
JP2012503623A (en) 2008-09-24 2012-02-09 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Pyrazole compounds for invertebrate pest control
US8809344B2 (en) 2008-10-29 2014-08-19 Apath, Llc Compounds, compositions, and methods for control of hepatitis C viral infections
EP2352725A1 (en) 2008-11-07 2011-08-10 Wyeth LLC Quinoxaline-based lxr modulators
CN102325754B (en) 2009-01-19 2014-03-12 第一三共株式会社 Cyclic compound having hetero atom
WO2010083199A1 (en) 2009-01-19 2010-07-22 Abbott Laboratories Benzthiazole inhibitors of poly(adp-ribose)polymerase
PT2403499T (en) 2009-03-02 2019-12-19 Stemsynergy Therapeutics Inc Methods and compositions for use in treating cancer and reducing wnt mediated effects in a cell
TW201041888A (en) 2009-05-06 2010-12-01 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US20120141483A1 (en) 2009-06-04 2012-06-07 Mary Katherine Delmedico Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives
US20110021531A1 (en) 2009-07-27 2011-01-27 Chobanian Harry Oxazole derivatives useful as inhibitors of faah
EP2470183B1 (en) 2009-08-26 2015-09-16 Merck Sharp & Dohme Corp. Heterocyclic amide compounds as protein kinase inhibitors
WO2011045415A2 (en) 2009-10-15 2011-04-21 Guerbet New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
UY33001A (en) 2009-11-06 2011-05-31 Boehringer Ingelheim Int And aryl derivatives and heteroarylcarbonyl hexahydroindenopyridine octahidrobenzoquinolina
JP2013032290A (en) * 2009-11-20 2013-02-14 Dainippon Sumitomo Pharma Co Ltd Novel fused pyrimidine derivative
WO2011072064A1 (en) 2009-12-08 2011-06-16 Array Biopharma Inc. S piro [chroman - 4, 4 ' - imidazol] ones as beta - secretase inhibitors
FR2953837B1 (en) 2009-12-10 2012-03-09 Sanofi Aventis Disubstituted 9h-pyridino [3,4-b] indole derivatives, their preparation and their therapeutic use
WO2011079000A1 (en) 2009-12-22 2011-06-30 Schering Corporation DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b]PURIN-4(5H)-ONE AND METHODS OF USE THEREOF
US8981084B2 (en) 2010-01-13 2015-03-17 Tempero Pharmaceuticals, Inc. Oxadiazole HDAC inhibitors
US20130030000A1 (en) 2010-01-28 2013-01-31 Chobanian Harry R Pharmaceutical compositions for the treatment of pain and other indications
US20110190266A1 (en) 2010-02-04 2011-08-04 Daniel Chu 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
WO2011117381A1 (en) 2010-03-26 2011-09-29 Boehringer Ingelheim International Gmbh B-raf kinase inhibitors
JP5871897B2 (en) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pyridyltriazole
EP2371219A1 (en) 2010-04-01 2011-10-05 Basf Se Herbicidal acylhydrazides
CN103079558A (en) 2010-04-05 2013-05-01 满康德股份有限公司 IRE-1[alpha] inhibitors
AU2011242961B2 (en) 2010-04-22 2015-09-24 Merck Sharp & Dohme Corp. Oxazole derivatives useful as modulators of FAAH
WO2011133727A2 (en) 2010-04-23 2011-10-27 Kineta, Inc. Anti-viral compounds
EP2401915A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
CN102048738A (en) 2010-12-08 2011-05-11 辽宁利锋科技开发有限公司 Medicament combination preparation of medicinal compound containing cy-ethyl razepam
LT2736887T (en) 2011-07-29 2018-02-12 Karyopharm Therapeutics, Inc. Hydrazide containing nuclear transport modulators and uses thereof
WO2013019561A1 (en) 2011-07-29 2013-02-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
JP2013159564A (en) * 2012-02-02 2013-08-19 Kowa Co Tlr9 inhibitor including pyrazolopyrimidine-7-amine derivative as active ingredient
ES2615268T3 (en) 2012-02-13 2017-06-06 Bristol-Myers Squibb Company Enediine compounds, conjugates thereof and uses and methods for it
SI2855476T1 (en) 2012-05-31 2018-12-31 Eisai R&D Management Co., Ltd. Tetrahydropyrazolopyrimidine compounds
PE20150229A1 (en) 2012-05-31 2015-03-02 Phenex Pharmaceuticals Ag Thiazoles substituted by carboxamide or sulfonamide and related derivatives as modulators for the orphan nuclear receptor rory

Also Published As

Publication number Publication date
SI2855476T1 (en) 2018-12-31
CN104507939A (en) 2015-04-08
HK1203498A1 (en) 2015-10-30
SG11201407890VA (en) 2014-12-30
AR091236A1 (en) 2015-01-21
HUE040562T2 (en) 2019-03-28
EP2855476A2 (en) 2015-04-08
DK2855476T3 (en) 2018-12-17
US9850242B2 (en) 2017-12-26
LT2855476T (en) 2019-01-10
CL2014003278A1 (en) 2015-06-12
PT2855476T (en) 2018-12-03
US20160030430A1 (en) 2016-02-04
CN104507939B (en) 2017-07-25
MX2014014497A (en) 2015-06-02
US20160339032A1 (en) 2016-11-24
RU2733959C2 (en) 2020-10-08
HRP20181889T1 (en) 2019-01-11
US9446046B2 (en) 2016-09-20
PH12014502660A1 (en) 2015-01-21
AU2013267204B2 (en) 2017-04-06
MX368455B (en) 2019-10-03
PL2855476T3 (en) 2019-02-28
US9126999B2 (en) 2015-09-08
WO2013181579A2 (en) 2013-12-05
RU2018146532A3 (en) 2019-06-21
TW201402575A (en) 2014-01-16
RU2014154397A (en) 2016-07-27
AU2013267204A1 (en) 2015-01-29
CN107344941B (en) 2020-04-21
TWI572606B (en) 2017-03-01
PH12014502660B1 (en) 2015-01-21
NZ703459A (en) 2016-09-30
RU2018146532A (en) 2019-01-31
RU2677291C2 (en) 2019-01-16
UA113440C2 (en) 2017-01-25
IL235986A (en) 2019-11-28
IL235986D0 (en) 2015-02-01
JP2018087221A (en) 2018-06-07
KR20150016366A (en) 2015-02-11
CN107344941A (en) 2017-11-14
JP6619829B2 (en) 2019-12-11
AU2013267204A8 (en) 2017-04-13
US20200347050A1 (en) 2020-11-05
PE20150220A1 (en) 2015-02-14
CA2874445A1 (en) 2013-12-05
WO2013181579A3 (en) 2014-03-27
JP6285918B2 (en) 2018-02-28
JP2015523981A (en) 2015-08-20
AU2017204586B2 (en) 2018-11-08
US10640500B2 (en) 2020-05-05
PE20190973A1 (en) 2019-07-09
US20180273532A1 (en) 2018-09-27
AU2013267204B8 (en) 2017-04-13
US20130324547A1 (en) 2013-12-05
RS57977B1 (en) 2019-01-31
BR112014030060A2 (en) 2017-09-12
ES2709119T3 (en) 2019-04-15
EP2855476B1 (en) 2018-09-05
ZA201409273B (en) 2016-05-25
AU2017204586A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
IL254716A (en) Zinc-lysine complex
IL253775D0 (en) נוגדנים בעלי שרשרת קלה מהונדסת היסטידין ובעלי חיים לא אנושיים שעברו שינוי גנטי להכנתם
HK1245780B (en) Imidazopyrrolidinone compounds
IL268013D0 (en) Tetrahydropyrazolopyrimidine compounds
HK1215183A1 (en) Protein-polymer-drug conjugates --
HK1208025A1 (en) Aminoimidazopyridazines
HK1201819A1 (en) Novel compounds
IL237341D0 (en) Pro-neurogenic compounds
GB201304182D0 (en) No details
EP2842955A4 (en) Trk-INHIBITING COMPOUND
EP2934531A4 (en) Combination
HK1200830A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
EP2754580A4 (en) Dumptruck
HRP20171150T1 (en) Novel compounds
DK3327112T3 (en) Agse-deficient stamme
GB201403961D0 (en) No details
HK1201200A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1212985A1 (en) Novel compounds
GB201214750D0 (en) Compounds
GB201207406D0 (en) Novel compounds
EP2922550A4 (en) Novel compounds
GB201209138D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) Pro-neurogenic compounds